UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,836,892 shares of the medical device company's stock after purchasing an additional 18,282 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.92% of Cooper Companies worth $168,865,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Byrne Asset Management LLC purchased a new stake in Cooper Companies in the fourth quarter worth about $33,000. OFI Invest Asset Management bought a new position in shares of Cooper Companies during the 4th quarter valued at approximately $34,000. New Age Alpha Advisors LLC purchased a new stake in Cooper Companies in the 4th quarter worth approximately $38,000. Covestor Ltd increased its holdings in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares in the last quarter. Finally, Atala Financial Inc bought a new stake in Cooper Companies during the 4th quarter worth approximately $51,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Wednesday. Robert W. Baird lowered their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Citigroup cut their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Thursday. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Price Performance

Shares of COO traded down $0.47 during midday trading on Friday, hitting $78.83. 1,548,951 shares of the company traded hands, compared to its average volume of 1,493,548. The stock has a market cap of $15.76 billion, a price-to-earnings ratio of 40.43, a PEG ratio of 2.25 and a beta of 1.08. The firm has a 50 day moving average of $80.25 and a 200-day moving average of $89.14. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.